These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
23. Corneal graft failure due to migration of Ozurdex™ implant into the anterior chamber. Madi HA; Morgan SJ; Ghosh S Am J Ophthalmol Case Rep; 2017 Dec; 8():25-27. PubMed ID: 29260111 [TBL] [Abstract][Full Text] [Related]
24. Resolution of refractory macular edema because of branch retinal vein occlusion after ozurdex implantation. Kay CN; Elkins KA; Folk JC Retin Cases Brief Rep; 2012; 6(1):72-5. PubMed ID: 25390716 [TBL] [Abstract][Full Text] [Related]
25. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema. Rahimi M; Shahrzad SS; Banifatemi M Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801 [TBL] [Abstract][Full Text] [Related]
26. Complications of dexamethasone implants: risk factors, prevention, and clinical management. Celik N; Khoramnia R; Auffarth GU; Sel S; Mayer CS Int J Ophthalmol; 2020; 13(10):1612-1620. PubMed ID: 33078113 [TBL] [Abstract][Full Text] [Related]
27. Management of anterior chamber dislocation of dexamethasone implant. Kishore SA; Schaal S Ocul Immunol Inflamm; 2013; 21(1):90-1. PubMed ID: 23323589 [TBL] [Abstract][Full Text] [Related]
28. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker. Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G Retina; 2014 Aug; 34(8):1612-6. PubMed ID: 24752008 [TBL] [Abstract][Full Text] [Related]
29. Migration of a Dexamethasone Intravitreal Implant to the Anterior Chamber in a Patient with a Intra-Scleral Haptic Fixated Intraocular Lens. Jamshidi F; Shah VA; Riaz KM Int Med Case Rep J; 2021; 14():633-635. PubMed ID: 34566437 [TBL] [Abstract][Full Text] [Related]
30. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239 [TBL] [Abstract][Full Text] [Related]
31. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab. Weiss K; Steinbrugger I; Weger M; Ardjomand N; Maier R; Wegscheider BJ; Wedrich A; El-Shabrawi Y Eye (Lond); 2009 Sep; 23(9):1812-8. PubMed ID: 19169227 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Chang-Lin JE; Burke JA; Peng Q; Lin T; Orilla WC; Ghosn CR; Zhang KM; Kuppermann BD; Robinson MR; Whitcup SM; Welty DF Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4605-9. PubMed ID: 21421864 [TBL] [Abstract][Full Text] [Related]
34. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema. Konstantopoulos A; Williams CP; Luff AJ Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463 [TBL] [Abstract][Full Text] [Related]
35. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075 [TBL] [Abstract][Full Text] [Related]